Ofev approved for an ILD other than IPF
This is potentially huge — and good — news for those of us who don’t have IPF. This approval is for those who have Scleroderma, but according to my nurse practitioner other clinical trials are showing equally encouraging results for pulmonary fibrosis caused by other autoimmune disorders. She expects FDA approval will get pushed through quickly.
Log in to reply.